hydroxyurea

(redirected from Droxia)
Also found in: Medical, Encyclopedia.

hy·drox·y·u·re·a

 (hī-drŏk′sē-yo͝o-rē′ə)
n.
An antineoplastic drug, CH4N2O2, that suppresses the production of blood cell precursors in the bone marrow and is used in the treatment of certain leukemias, carcinomas, and sickle cell anemia.

hydroxyurea

(haɪˌdrɒksɪjʊˈrɪə)
n
(Medicine) a drug which prevents the development of tumours and is used in the treatment of certain types of cancer as well as in the treatment of sickle-cell disease and AIDS
Translations

hydroxyurea

n hidroxiurea, hidroxicarbamida (INN)
Mentioned in ?
References in periodicals archive ?
The Food and Drug Administration is reviewing proposed label changes for Hydrea and Droxia (hydroxyurea capsules) that warn of cutaneous vasculitic toxicities.
Droxia is indicated to reduce the frequency of painful crises and to reduce the need for blood transfusions in adult patients with sickle cell anemia with recurrent moderate to severe painful crises.